Skip to content

Insider · CIK 0002055523

Amy E. Herr

director

Files at TECH (BIO-TECHNE Corp). First filing Feb 18, 2025, latest Feb 19, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $303k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TECH: BIO-TECHNE Corp

TECHOct 9, 2026 · close 72.46

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
45Moderate
TECHsell
BIO-TECHNE Corp
$117k
1,976 shares
-91%+26% from low-18% from high
18Weak
TECHsell
BIO-TECHNE Corp
$64k
1,280 shares
-39%+7% from low-38% from high
20Weak
TECHsell
BIO-TECHNE Corp
$123k
1,860 shares
-48%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 17, 2026TECH
BIO-TECHNE Corp
SOpen-market sale
Common Stockindirect: By significant other
-1,976$59.11$117k200Feb 19, 2026
Feb 3, 2026TECH
BIO-TECHNE Corp
MOption exercise
Common Stockindirect: By significant other
+38$0.00$02,192Feb 5, 2026
Feb 3, 2026TECH
BIO-TECHNE Corp
FTax withholding
Common Stockindirect: By significant other
-16$64.63$1,0342,176Feb 5, 2026
Feb 3, 2026TECH
BIO-TECHNE Corp
MOption exercise
Restricted Stock Unitsderivativeindirect: By significant other
-38$0.00$077Feb 5, 2026
Oct 30, 2025TECH
BIO-TECHNE Corp
AGrant or award
Common Stock
+1,640$0.00$02,680Nov 3, 2025
Oct 30, 2025TECH
BIO-TECHNE Corp
AGrant or award
Stock Option (Right to Buy)derivative
+3,777$0.00$03,777Nov 3, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
MOption exercise
Common Stockindirect: By significant other
+279$0.00$02,255Aug 19, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
FTax withholding
Common Stockindirect: By significant other
-101$53.60$5,4142,154Aug 19, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
MOption exercise
Restricted Stock Unitsderivativeindirect: By significant other
-119$0.00$0118Aug 19, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
MOption exercise
Restricted Stock Unitsderivativeindirect: By significant other
-160$0.00$0320Aug 19, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
AGrant or award
Restricted Stock Unitsderivativeindirect: By significant other
+932$0.00$0932Aug 19, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
AGrant or award
Stock Option (Right to Buy)derivativeindirect: By significant other
+2,735$0.00$02,735Aug 19, 2025
Jun 9, 2025TECH
BIO-TECHNE Corp
MOption exercise
Common Stockindirect: By significant other
+1,280$44.33$57k3,256Jun 11, 2025
Jun 9, 2025TECH
BIO-TECHNE Corp
SOpen-market sale
Common Stockindirect: By significant other
-1,280$49.77$64k1,976Jun 11, 2025
Jun 9, 2025TECH
BIO-TECHNE Corp
MOption exercise
Stock Option (Right to Buy)derivativeindirect: By significant other
-1,280$0.00$00Jun 11, 2025
Feb 14, 2025TECH
BIO-TECHNE Corp
MOption exercise
Common Stockindirect: By significant other
+1,976$44.33$88k3,836Feb 18, 2025
Feb 14, 2025TECH
BIO-TECHNE Corp
SOpen-market sale
Common Stockindirect: By significant other
-1,860$65.96$123k1,976Feb 18, 2025
Feb 14, 2025TECH
BIO-TECHNE Corp
MOption exercise
Stock Option (Right to Buy)derivativeindirect: By significant other
-1,976$0.00$01,280Feb 18, 2025
Feb 3, 2025TECH
BIO-TECHNE Corp
AGrant or award
Common Stock
+1,040$0.00$01,040Feb 7, 2025
Feb 3, 2025TECH
BIO-TECHNE Corp
AGrant or award
Stock Option (Right to Buy)derivative
+2,415$0.00$02,415Feb 7, 2025
Feb 3, 2025TECH
BIO-TECHNE Corp
AGrant or award
Stock Option (Right to Buy)derivativeindirect: By significant other
+344$0.00$0344Feb 7, 2025
Feb 3, 2025TECH
BIO-TECHNE Corp
AGrant or award
Restricted Stock Unitsderivativeindirect: By significant other
+115$0.00$0115Feb 7, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Amy E. Herr: insider trades and track record | InsiderTell